240 related articles for article (PubMed ID: 36369105)
1. Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes.
Pedersen DC; Jensen BW; Tjønneland A; Andersen ZJ; Mellemkjaer L; Bjerregaard LG; Aarestrup J; Baker JL
Breast Cancer Res; 2022 Nov; 24(1):77. PubMed ID: 36369105
[TBL] [Abstract][Full Text] [Related]
2. Early life body size, pubertal timing, and risks of benign breast disease in a large cohort of Danish female adolescents and women.
Aarestrup J; Jensen BW; Pedersen DC; Kroman N; Mellemkjær L; Baker JL; Bjerregaard LG
Eur J Pediatr; 2022 Aug; 181(8):3023-3030. PubMed ID: 35652986
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of body mass index across the lifecourse and associations with post-menopausal breast cancer by estrogen receptor status.
Pedersen DC; Aarestrup J; Blond K; Jensen BW; Andersen ZJ; Mellemkjær L; Tjønneland A; Baker JL
Cancer Epidemiol; 2023 Dec; 87():102479. PubMed ID: 37897969
[TBL] [Abstract][Full Text] [Related]
4. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
5. Early life body size and puberty markers as predictors of breast cancer risk later in life: A neural network analysis.
Svendsen SMS; Pedersen DC; Jensen BW; Aarestrup J; Mellemkjær L; Bjerregaard LG; Baker JL
PLoS One; 2024; 19(2):e0296835. PubMed ID: 38335218
[TBL] [Abstract][Full Text] [Related]
6. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.
van den Brandt PA; Ziegler RG; Wang M; Hou T; Li R; Adami HO; Agnoli C; Bernstein L; Buring JE; Chen Y; Connor AE; Eliassen AH; Genkinger JM; Gierach G; Giles GG; Goodman GG; Håkansson N; Krogh V; Le Marchand L; Lee IM; Liao LM; Martinez ME; Miller AB; Milne RL; Neuhouser ML; Patel AV; Prizment A; Robien K; Rohan TE; Sawada N; Schouten LJ; Sinha R; Stolzenberg-Solomon RZ; Teras LR; Tsugane S; Visvanathan K; Weiderpass E; White KK; Willett WC; Wolk A; Zeleniuch-Jacquotte A; Smith-Warner SA
Eur J Epidemiol; 2021 Jan; 36(1):37-55. PubMed ID: 33128203
[TBL] [Abstract][Full Text] [Related]
7. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
[TBL] [Abstract][Full Text] [Related]
8. Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies.
Fortner RT; Brantley KD; Tworoger SS; Tamimi RM; Rosner B; Holmes MD; Willett WC; Eliassen AH
Breast Cancer Res Treat; 2024 Jul; 206(1):77-90. PubMed ID: 38592542
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
[TBL] [Abstract][Full Text] [Related]
10. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
11. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
12. Association of breast cancer subtypes and body mass index.
Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China.
Li J; Huang Y; Zhang BN; Fan JH; Huang R; Zhang P; Wang SL; Zheng S; Zhang B; Yang HJ; Xie XM; Tang ZH; Li H; He JJ; Hsieh E; Qiao YL; Li JY
PLoS One; 2014; 9(1):e87224. PubMed ID: 24489874
[TBL] [Abstract][Full Text] [Related]
14. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
[TBL] [Abstract][Full Text] [Related]
15. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
16. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.
Horn J; Alsaker MD; Opdahl S; Engstrøm MJ; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Asvold BO
Int J Cancer; 2014 Dec; 135(11):2678-86. PubMed ID: 24752603
[TBL] [Abstract][Full Text] [Related]
17. Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa.
Jørgensen AR; Aarestrup J; Baker JL; Thomsen SF
JAMA Dermatol; 2020 Jul; 156(7):746-753. PubMed ID: 32347905
[TBL] [Abstract][Full Text] [Related]
18. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.
Kawai M; Malone KE; Tang MT; Li CI
Cancer; 2014 May; 120(10):1548-56. PubMed ID: 24500704
[TBL] [Abstract][Full Text] [Related]
19. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
Ritte R; Lukanova A; Tjønneland A; Olsen A; Overvad K; Mesrine S; Fagherazzi G; Dossus L; Teucher B; Steindorf K; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita B; van Duijnhoven F; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Krum-Hansen S; Gram IT; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; McCormack V; Riboli E; Kaaks R
Int J Cancer; 2013 Jun; 132(11):2619-29. PubMed ID: 23090881
[TBL] [Abstract][Full Text] [Related]
20. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
